5GX-19028-18533
5 vaccinations
4 coded responses
58 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 454 / OH
- Registered
- 2021-03-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-02
Registered in v-safe
-
2021-03-02
Dose 1 — Moderna
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-16
-
2021-03-23
Survey response — day 21, dose 1MedDRA: Fatigue — Feeling: GoodFree text: Physically and mentally tired. Has increased over the past couple of weeks. Have experienced similar when prescribed a new medication but not usually this long term with a vaccine. I'm definitely sleeping well.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-30
Dose 2 — Moderna
- 2021-03-30
-
2021-03-31
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-13
- 2021-04-20
- 2021-04-27
- 2021-05-04
-
2021-05-13
Survey response — day 42, dose 2MedDRA: Ageusia, Anosmia, Cough, Exposure to SARS-CoV-2, Headache, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test negative — Feeling: GoodFree text: Exposed to someone who tested Covid positive 5 days later. 4 days post exposure I developed, cough, congestion, headache, fever. PCR was negative. 3 days later I experienced altered/decreased taste and smell. Again tested negative.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-01
Survey response — 3 months, dose 2MedDRA: Ageusia, Anosmia, Body temperature increased, Cough, Exposure to SARS-CoV-2, Malaise, Respiratory tract congestion, SARS-CoV-2 test negative — Feeling: GoodFree text: 2 hr exposure to 3 people 4/30/21. All tested + 5/5. I had sx onset 5/4. Tested neg 5/6 with mild cough/cong/100.5 temp. Lost taste/smell 5/7. All sx resolved < 10 days post onset. Do continue to have random taste/smell issues that dissipate quickly.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-28
-
2021-10-26
Dose 3 — Moderna
-
2021-10-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-09
- 2021-11-16
- 2021-11-23
- 2021-11-30
- 2021-12-07
- 2022-01-25
-
2022-04-13
Dose 4 — Moderna
- 2022-04-18
- 2022-04-19
- 2022-04-20
- 2022-04-27
- 2022-05-04
- 2022-05-11
- 2022-05-18
- 2022-05-25
- 2022-07-13
-
2022-09-28
Dose 5 — Moderna
-
2022-09-30
Survey response — days 1–6 daily, dose 5MedDRA: Injection site erythema, Injection site pruritus — Feeling: Good · Site: Pain, Redness, Swelling, ItchingFree text: Area of redness and itching is 4" x 4MedDRA releases: 2024-11 · check-in free text available
-
2022-10-01
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2022-10-02
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Redness, Itching · NoneAdult check-in
-
2022-10-03
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Redness, Itching · NoneAdult check-in
- 2022-10-04
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-10-26
- 2022-11-02
- 2022-11-09
- 2022-12-28
- 2023-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-02 | Moderna | |
| 2 | 2021-03-30 | Moderna | |
| 3 | 2021-10-26 | Moderna | No |
| 4 | 2022-04-13 | Moderna | No |
| 5 | 2022-09-28 | Moderna | No |
Free text
Release 6 — day 21, dose 1
Symptoms: Physically and mentally tired. Has increased over the past couple of weeks. Have experienced similar when prescribed a new medication but not usually this long term with a vaccine. I'm definitely sleeping well.
Release 8 — day 42, dose 2
Symptoms: Exposed to someone who tested Covid positive 5 days later. 4 days post exposure I developed, cough, congestion, headache, fever. PCR was negative. 3 days later I experienced altered/decreased taste and smell. Again tested negative.
Release 9 — 3 months, dose 2
Symptoms: 2 hr exposure to 3 people 4/30/21. All tested + 5/5. I had sx onset 5/4. Tested neg 5/6 with mild cough/cong/100.5 temp. Lost taste/smell 5/7. All sx resolved < 10 days post onset. Do continue to have random taste/smell issues that dissipate quickly. cut off by CDC
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Area of redness and itching is 4" x 4
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | ✓ | ✓ | ✓ |
| SD | Anosmia | ✓ | ✓ | ✓ |
| SD | Body temperature increased | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Exposure to SARS-CoV-2 | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Malaise | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | · | · | ✓ |
| SRO | Injection site pruritus | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release